Clinical trials
Atrial Fibrillation, Paroxysmal or Persistent clinical trials
Below are recruiting atrial fibrillation, paroxysmal or persistent clinical trials, each written for real people, not researchers. We’re tracking 469 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06817395Recruiting
Thinking and memory in chronic ITP
This study looks at whether chronic or persistent immune thrombocytopenia (ITP) affects thinking and memory. If you have had low platelet counts for 3 months or more and have been treated for ITP, you may help researchers understand how the condition can impact the brain.
Boston, MassachusettsAges 18 years+ - NCT06804525Recruiting
Adapting a mental health survey in Hong Kong
This study adapts a mental health survey for Hong Kong adults. It is open to adults aged 25 and older who live in randomly selected households and can speak Chinese or English.
Hong KongAges 25 years+ - NCT06810180Recruiting
Sleep, activity, and daily rhythms in ADHD
This study looks at how sleep, physical activity, and daily rhythms affect thinking and behavior in people with ADHD. It may help find ways to improve symptoms through better sleep and activity habits.
Baltimore, MarylandAges 8–12 - NCT06795763Enrolling by invitation
New imaging & catheter system for blocked heart arteries
This trial tests a new imaging and catheter system to treat chronic total blockages in heart arteries. If you still have chest pain or other symptoms despite medical therapy, this study may help open the blockage and improve blood flow.
Atlanta, GeorgiaAges 18 years+ - NCT06785909Recruiting
Understanding why pregnancy back and pelvic pain persists
This study looks at why some women develop ongoing pain in the lower back or pelvis during pregnancy. It tests how your body's sense of movement, fear of pain, and inflammation might be related. You may join if you are early in a single pregnancy and do not have that pain yet.
HasseltAges 18–40 - NCT06786832Recruiting
Trial for fatigued patients in primary care
This trial studies severe fatigue that started at a specific time and is not due to another illness. It aims to find better ways to diagnose, treat, and support people with long-term fatigue in primary care.
Stockholm, GustavsbergAges 18–67 - NCT05966493RecruitingPhase 2
Lufepirsen gel for persistent corneal epithelial defects
This Phase 2 trial tests whether a treatment gel called NEXAGON (lufepirsen) can improve healing and safety in people with a persistent corneal problem called PCED that hasn’t gotten better despite standard non-surgical treatments. You may be a candidate if your defect has lasted at least 2 weeks and hasn’t improved recently, and if you don’t have certain eye infections or other eye conditions.
Dothan, AlabamaAges 2 years+ - NCT06764693Recruiting
Study on treatment with Risankizumab for psoriatic arthritis
This study tests how well a medicine called Risankizumab works for people with psoriatic arthritis. It is for adults who have had symptoms for at least 6 months and have not had enough help from at least one other arthritis medicine.
Quilmes, Buenos AiresAges 18–75 - NCT06755515Enrolling by invitationPhase 2/Phase 3
Rulonilimab + Chemo for Advanced Cervical Cancer
This trial tests a new drug called Rulonilimab combined with chemotherapy, with or without bevacizumab, as the first treatment for cervical cancer that has spread or come back. It’s for people whose tumors have a specific marker (PD-L1) and who haven’t had other treatments for advanced disease.
Linyi, ShandongAges 18 years+ - NCT06680739RecruitingPhase 2
Study of immunotherapy for colorectal and endometrial cancer
This trial tests two immunotherapy drugs, durvalumab and tremelimumab, in people with colorectal or endometrial cancer that has spread or come back. The goal is to understand why some tumors persist or don't respond to treatment.
BarcelonaAges 18 years+ - NCT06631287RecruitingPhase 3
Testing baricitinib for persistent long COVID symptoms
This trial tests whether the anti-inflammatory drug baricitinib can improve persistent long COVID symptoms like brain fog, fatigue, and shortness of breath. You may qualify if you had COVID-19 at least 6 months ago and still have bothersome symptoms that affect your daily life.
Tucson, ArizonaAges 18 years+ - NCT06593977Recruiting
Dynavisc gel for pain after repeat carpal tunnel surgery
This trial tests a gel called Dynavisc to see if it reduces pain when placed in the wrist during a second surgery for carpal tunnel syndrome. It may help people who still have pain after their first surgery.
Leuven, BelgiumAges 18–65 - NCT06577467Recruiting
Studying leftover virus after covid recovery
This study looks for signs of leftover SARS-CoV-2 virus in people who have fully recovered from COVID-19, including those with ongoing neurological symptoms (like brain fog, fatigue, or nerve pain). It aims to understand why some people have long-lasting symptoms after infection.
Bethesda, MarylandAges 18–110 - NCT06576219Enrolling by invitation
My Life is Music group therapy for teens with persistent pain
This study tests whether a group therapy program called 'My Life is Music' can help teenagers with ongoing pain. It looks at how well the program works and if it's a good fit for teens.
HelsinkiAges 13–17 - NCT06566430Recruiting
PrEP My Way: Helping young women stay on PrEP
This study tests whether a program called 'PrEP My Way' can help young women in Kenya stick with taking PrEP pills to prevent HIV. It's designed for women ages 16–24 who are just starting PrEP in Kisumu County.
KisumuAges 16–24 - NCT06499363Recruiting
Treprostinil for pulmonary hypertension in newborns
This study collects information on how well a medicine called treprostinil works and how safe it is for newborn babies with pulmonary hypertension (high blood pressure in the lungs). It is for babies who have already received this treatment as part of their regular care.
BronAges Up to 10 months - NCT06540729RecruitingPhase 2
Combination treatment for ovarian clear cell cancer
This trial tests a combination of three drugs (RC48, AK104, and bevacizumab) for ovarian clear cell carcinoma, a type of ovarian cancer. The goal is to see if this combination can help shrink or control the cancer in people who have not had many prior treatments.
Guanzhou, GuangdongAges 18–75 - NCT06528041Recruiting
Chicory fiber and gut health study
This study tests whether a natural fiber from chicory root can change and keep changes in your gut bacteria. It may help improve digestion and overall health.
West Lafayette, IndianaAges 18–45 - NCT06513026Recruiting
Milk for diabetes prevention
This study tests whether drinking milk daily can help prevent type 2 diabetes in people with prediabetes and a specific gene variation. You'll be asked to drink milk or a placebo drink for several weeks while researchers monitor your blood sugar and health.
The Bronx, New YorkAges 18–70 - NCT06484686Enrolling by invitationPhase 4
Long-term immunity study of chickenpox vaccine booster
This study follows up people who were in a previous phase 3 chickenpox vaccine trial. It checks how long protection from a booster dose lasts, by taking a blood sample.
Zhengzhou, HenanAges 8–16 - NCT06472102Recruiting
Heart nerve ablation for severe fainting
This study tests a procedure called cardioneuroablation, which uses targeted heat (radiofrequency) to calm overactive nerves that cause your heart to beat too slowly and make you faint. The goal is to stop severe fainting spells in people with reflex syncope who haven't gotten better with other treatments.
Warsaw, Masovian VoivodeshipAges 14 years+ - NCT05677412Recruiting
Studying sleep, stress, and pain in teens with ongoing pain
This study looks at how sleep and stress relate to pain that keeps coming back in teens. It may help researchers understand what could improve comfort and daily functioning when pain lasts more than three months.
HelsinkiAges 15–17 - NCT06367738RecruitingPhase 1
Psilocybin and brain changes in healthy older adults
This study looks at how a single dose of psilocybin (the active ingredient in magic mushrooms) affects brain structure in healthy older adults. You'll receive the drug in a safe setting and have brain scans before and after to see if it promotes positive changes.
Berkeley, CaliforniaAges 60–85 - NCT06368388Recruiting
Personalized phage therapy for hard-to-treat infections
This trial studies using phages (viruses that attack bacteria) to treat infections that have not improved with other treatments. It aims to see if this patient-specific approach works and what it costs.
LeuvenAges Any age
Hear when a new Atrial Fibrillation, Paroxysmal or Persistent trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for atrial fibrillation, paroxysmal or persistent?
- Yes. Clin2 currently lists 469 recruiting atrial fibrillation, paroxysmal or persistent studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a atrial fibrillation, paroxysmal or persistent trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a atrial fibrillation, paroxysmal or persistent trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.